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Abstract
Turkey and chicken interferon-g (IFN-g) share high identity (96.3% and 97% at the nucleotide and amino acid
level, respectively). As such, we predicted that they would be functionally cross-reactive. To test this hypothesis, we
produced recombinant turkey and chicken IFN-g, and compared their biological properties. Recombinant turkey
and chicken IFN-g both induce HD11 cells (a chicken macrophage cell line) and LSTC-IAH30 cells (ALV-J-
transformed turkey macrophages) to produce nitric oxide (NO), as measured in an avian IFN-g bioassay. Polyclonal
and monoclonal antibodies, capable of neutralising the eect of chicken IFN-g on HD11 cells, were also shown to
inhibit the activity of turkey IFN-g on these cells. The antibody neutralisation eect on both turkey and chicken
IFN-g was shown by a significant reduction in NO production by HD11 cells when the neutralising antibodies were
present in the bioassay. FACS analysis showed that HD11 and LSTC-IAH30 cells share some cell surface
markers. 7 2000 Elsevier Science Ltd. All rights reserved.
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1. Introduction
At present the cDNAs for only three turkey
cytokines have been cloned: type I IFN [1], IFN-g
[2] and IL-2 [3]. Turkey type I IFN shares 91%
and 82% identity with chicken type I IFN at the
nucleotide (nt) and amino acid (aa) sequence
levels, respectively. Chicken and turkey type I
IFN have also been shown to be cross-reactive [1].
Turkey and chicken IL-2 share 86.2% and 69.9%
identity at the nt and aa sequence levels respect-
ively and are less conserved than IL-2 from closely
related mammalian species [3]. Despite this low
degree of identity at the aa level, turkey and
chicken IL-2 are cross-reactive. In comparison,
turkey IFN-g (TuIFN-g) shares 96.3% and 97%
identity with chicken IFN-g (ChIFN-g) at the nt
and aa sequence levels, respectively [2]. The high
degrees of identity seen among the galliforms for
IFN-g (93.5–96.7% and 87.8–96.6% at the nt and
aa levels, respectively) suggested cross-species
reactivity [2]. To test this hypothesis, recombinant
IFN-g from turkey and chicken were produced in
order to compare their biological properties.
IFN-g is a pleiotropic cytokine involved in the
regulation of nearly every stage of immune and in-
flammatory responses. It is associated primarily
with a T helper 1 immune response, driving cell-
mediated immunity. IFN-g augments the ex-
pression of MHC class II antigens on many dier-
ent accessory cells, thus stimulating the interaction
of these cells with T cells, promoting antibody
(Ab) IgG2a isotype switching and the develop-
ment of cytotoxic T cells. Its primary function is
to activate resting macrophages, which once acti-
vated kill pathogens within cells. Macrophages
activated by IFN-g produce reactive nitrogen
species, including nitric oxide (NO) [4]. We used
this property to measure the ability of recombi-
nant ChIFN-g (rChIFN-g) and recombinant
TuIFN-g (rTuIFN-g) to stimulate turkey or
chicken macrophages.
2. Materials and methods
2.1. Animals
Big 6 line turkeys (British United Turkeys)
were obtained at hatch from Sun Valley Foods
Ltd., Ludlow, Shropshire, UK, and maintained
at IAH. Chickens (Sykes Rhode Island Reds)
were produced and maintained at IAH.
2.2. Culture of the turkey macrophage cell line,
LSTC-IAH30, and the chicken macrophage cell
line, HD11
Turkey macrophages were isolated from per-
ipheral blood of four week-old poults. 10 ml of
heparinised blood was centrifuged over Histo-
paque 1083 (Sigma, Poole, UK) at 1200  g for
40 min at 4oC and the leukocyte fraction col-
lected. Cells were washed three times in Dulbec-
co’s Modified Eagle’s Medium (DMEM) (Life
Technologies, Paisley, UK) and then counted. 5
 106 leukocytes were seeded into 50 mm petri
dishes in 5 ml of growth media (an equal volume
of Leibovitz L15 medium (Life Technologies)
and McCoy’s 5A medium (Life Technologies)
containing 5% fetal bovine serum (FBS) and 5%
chick serum (CS)) and incubated at 38.5oC in
5% CO2. The medium was changed each day for
4 days. The cells were then challenged with 103
chicken bone marrow cell-transforming units of
acutely transforming avian leukosis virus (ALV)
strain 966 [5], absorbed for 1 h at 38.5oC in 5%
CO2. Fresh medium was then added. The med-
ium was then changed every 2–3 days until the
cultures were completely transformed (10–14
days). The transformed cells were then main-
tained by subculture. Every 3–4 days, cells were
passaged, using standard conditions [6] and
seeded at 4  104 mlÿ1 of growth media (an
equal volume of Leibovitz L15 medium and
McCoy’s 5A medium, containing 8% FBS, 2%
CS, 5% tryptose phosphate broth (TPB), sodium
pyruvate (100 mM), 1 U/ml penicillin and 1 mg/
ml streptomycin), changing the media every 2
days. At intervals extracts of the cells were tested
for ALV group specific antigen by capture
ELISA and for acutely transforming virus in the
supernatant, by chicken bone marrow cell trans-
formation. All tests were positive (results not
shown). The resulting turkey macrophage cell
line, LSTC-IAH30, was cultured in an equal
volume of Leibovitz L15 medium and McCoy’s
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5A medium, containing 8% FBS, 2% CS, 5%
TPB, 100 mM sodium pyruvate, 1 U/ml penicil-
lin and 1 mg/ml streptomycin (P/S). Every 2 days,
cells were passaged and seeded at 4 104 mlÿ1.
HD11 cells, an ALV virus (MC29) transformed
chicken macrophage cell line [7], were cultured in
RPMI 1640 (Life Technologies) containing 2.5%
FCS, 2.5% CS, 10% TPB, 20 mM L-glutamine
and P/S. Every 3–4 days cells were passaged and
seeded at 4 105 mlÿ1.
2.3. Cloning and analysis of TuIFN-g and ChIFN-
g cDNA
mRNA was isolated from splenocytes from 3-
to 5-week-old turkey poults. Spleens were col-
lected aseptically in DMEM and tissue was bro-
ken up with sterile forceps. Leukocyte cell
suspensions were isolated by centrifugation over
Ficoll-Paque (Amersham Pharmacia Biotech, St
Albans, UK) at 1000  g for 20 min at 48C and
washed twice in DMEM. The cells were resus-
pended at 1  107 mlÿ1 in DMEM containing
1% L-glutamine, 2 mg mlÿ1 BSA and P/S. Cells
were stimulated with 0.8 mg mlÿ1 of PMA
(Sigma) and incubated at 418C in 5% CO2. Cells
were harvested and mRNA isolated at 6, 12, 18
and 24 h after PMA stimulation, using an Oligo-
tex Direct Midi kit (Qiagen, Crawley, UK). RT-
PCR were performed to obtain turkey and
chicken IFN-g cDNAs, encoding the signal
sequence and mature protein (including the stop
codon), using primers designed by Kaiser et al.
[2] to the chicken genomic IFN-g sequence
(Accession No. Y07922). Primer IFN3
(5 ’ATGACTTGCCAGACTTACAA 3 ’) corre-
sponds to nt positions 1–20 of the coding
sequence. Primer IFN4 (5 ’TTACGAATTG-
CATCTCCTCT 3 ’) is reverse complementary to
nt positions 495–475 in the cDNA.
First strand synthesis was for 2 h at 428C in a
20 ml volume, containing 4 pmol of the reverse
primer (IFN4), 200 U Superscript II (Life Tech-
nologies) and 500 ng mRNA. After denaturation
of the polymerase at 948C for 4 min, 10 ml of this
reaction mix was added as DNA template to a
50 ml standard PCR, containing 20 pmol of each
primer (IFN3 and IFN4) and 2.5 U Taq poly-
merase (Life Technologies). Cycling conditions
were 948C for 1 min, 558C for 2 min, 728C for 2
min, for 25 cycles, using a Hybaid TouchDown
PCR machine. The resulting PCR product was
ligated into pGEM-T Easy vector (Promega,
Southampton, UK) and the complete sequence of
five representative clones determined on each





Terminator cycle sequencing kit (Applied
Biosystems, Warrington, UK). Sequence data
was analysed with the Wisconsin Package soft-
ware (Genetics Computer Group; [8]). The
cDNA inserts were then ligated into the NotI site
of the expression vector pCIneo (Promega). The
resulting constructs were sequenced to confirm
that the IFN-g cDNAs were error-free and in the
correct orientations.
2.4. Expression of recombinant TuIFN-g and
ChIFN-g
COS-7 cells were routinely grown in DMEM
(containing 10% FBS, 1% non-essential aa, 1%
L-glutamine and P/S) at 378C in 5% CO2 and
passaged using standard conditions [6]. Cells
were cultured at 5  105 mlÿ1 for 18–24 h at
378C in 5% CO2, and washed twice with PBS. 5
ml of serum-free media was added, containing
7.5 mg mlÿ1 DNA (pCIneo containing either
TuIFNg or ChIFN-g (pTuIFNg or pChIFNg, re-
spectively), pCIneo alone or no plasmid), 258 mg
mlÿ1 chloroquine and 600 mg mlÿ1 DEAE-
dextran. Flasks were incubated for 3 h at 378C in
5% CO2. The transfection media were then
removed and the cells washed once with PBS.
PBS containing 10% dimethyl sulphoxide was
then added for 2 min, removed and replaced with
5 ml of growth media. After 24 h growth at 378C
in 5% CO2, growth media was replaced with
serum-free growth media. The cells were then
incubated for 72 h, following which supernatant
was collected and stored at 48C prior to use in
the IFN-g bioassays.
2.5. Bioassay and neutralisation assay
Immediately before use in the IFN-g bio-
assay, cells (LSTC-IAH30 and HD11) were
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trypsinised, adjusted to 5  105 mlÿ1 and added
(100 ml/well) to 96-well flat-bottomed plates
(Costar, Corning, NY, USA). Serial dilutions of
supernatants from transfected COS-7 cells, as
described above, were added, in triplicate, to give
a final volume of 200 ml/well. Negative controls
included supernatants collected from COS-7 cells
transfected with pCIneo alone, or no plasmid.
Lipopolysaccharide (LPS — E. coli serotype
055:B5) (Sigma) was used as a positive control,
with ten-fold serial dilutions starting at 10 mg
mlÿ1. All plates were then incubated at 418C in
5% CO2 for 48 h.
An IFN-g neutralising assay was set up
using either HD11 or LSTC-IAH30 cells at
the concentrations described in the IFN-g
bioassay. Anti-chicken IFN-g neutralising Abs,
mAb 1E-12 [9] and a rabbit polyclonal Ab 88
(kindly provided by J. Lowenthal, CSIRO,
Australia), were diluted 1:100 in HD11 or
LSTC-IAH30 cell media. 50 ml/well of Ab
were added to 96-well flat-bottomed plates in
triplicate and mixed with 50 ml of supernatants
from transfected COS-7 cells, as described
above, or LPS (diluted as described above).
An isotype matched anti-bovine CD4 mAb
CC30 [10], a polyclonal goat anti-mouse IgG
FITC conjugate (Cambridge Bioscience, UK)
and medium alone were used as negative con-
trols. After 1 h incubation at 48C, 100 ml of
HD11 or LSTC-IAH30 cells were added to
each well and incubated at 418C in 5% CO2
for 48 h.
Nitric oxide production from HD11 or
LSTC-IAH30 cells in the IFN-g bioassay or
IFN-g neutralising bioassay was measured
using a modification of the Griess assay.
Equal volumes of 1% sulfanilamide and 0.3%
naphthylethylenediamine, in 2.5% H3PO4, were
mixed and 100 ml/well added to 96-well flat-bot-
tomed plates. 100 ml/well of the supernatants
from the incubated HD11 or LSTC-IAH30 cells
were added to the substrate. Absorbance at 543
nm was read on a Spectra Max 250 ELISA
reader (Molecular Devices, Wokingham, UK).
For the neutralising bioassay, the results were
examined by one-way analysis of variance to
identify if there were any significant dierences
between the treatments. A Tukey test for mul-
tiple comparison of K population means was
then used to identify which treatments were sig-
nificantly dierent.
2.6. Capture ELISA
Splenic cell suspensions from chicken and tur-
keys were prepared essentially as described
above, and resuspended at 1  107 mlÿ1 in
DMEM containing 1% L-glutamine, 2 mg mlÿ1
BSA and P/S. Cells were stimulated with various
concentrations of ConA, LPS (in this assay, E.
coli serotype 0111:B4), PHA or PWM (all Sigma)
and incubated for 48 h at 418C in 5% CO2. The
resulting supernatants were assayed for IFN-g
content using a quantitative capture ELISA, as
described [9].
2.7. FACS analysis
Splenic cell suspensions from turkeys were pre-
pared essentially as described above. PBLs were
isolated from 5 ml of heparinised blood by cen-
trifugation at 48C for 15 min at 2100  g over
Ficoll-Paque and washed twice in DMEM.
HD11 and LSTC-IAH30 cells were passaged (as
described above). All cell suspensions were
adjusted to 2  107 mlÿ1 in cold PBS containing
2 mg mlÿ1 BSA and 0.1% sodium azide (PBS/
BSA/Azide).
Fifty microlitres of cells were added per well to
round-bottomed 96-well plates (Nunclon, Nunc,
Denmark) and centrifuged at 48C for 2 min at
150  g. Supernatants were removed and cells
resuspended in 25 ml of each of the dierent anti-
chicken mAb [10–17] (see Table 1) at optimum
dilutions in PBS/BSA/Azide. PBS/BSA/Azide
alone and CC30 were used as negative controls.
Plates were incubated at 48C for 45 min. Cells
were washed twice in 100 ml of PBS/BSA/Azide,
resuspended in 25 ml of goat anti-mouse IgG con-
jugated to FITC (Cambridge Bioscience) at a
1:200 dilution and incubated at 48C for 45 min.
The wash was repeated in 100 ml of PBS/BSA/
Azide and cells resuspended in 400 ml of sheath
fluid (normal saline). Each sample was analysed
on a FACScan (Becton Dickinson, Oxford, UK).
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The fluorescence (FL1) of 5000 cells in each
sample was measured.
3. Results
3.1. Turkey and chicken IFN-g cross-react
Turkey and chicken IFN-g cDNAs (encoding
the signal sequence and mature protein, including
the stop codon) were cloned separately into the
expression vector pCIneo and the resulting con-
structs (pTuIFN-g and pChIFN-g respectively)
sequenced to confirm the DNA insert was error-
free and in the correct orientation (results not
shown). Recombinant IFN-g was then produced
by transfecting COS-7 cells with pTuIFN-g or
pChIFN-g, and collecting supernatant after 72 h
incubation at 378C in 5% CO2. Controls
included COS-7 cells transfected with pCIneo
alone, and mock-transfected COS-7 cells. Identi-
cal supernatants were tested in all bioassays.
The species-specific activities of rTuIFN-g and
rChIFN-g were examined in an IFN-g bioassay
[7,18]. The assay works on the principle that
IFN-g activates macrophages to aid the killing of
intracellular pathogens in infected cells, by the
production of reactive nitrogen species, including
NO [4]. Here we measured the ability of rIFN-g
to induce chicken macrophages (HD11 cell line
[7]) or turkey macrophages (LSTC-IAH30 cell
line) to secrete NO, as measured by nitrite ac-
cumulation in the culture supernatants. LPS (E.
coli serotype 055:B5) also stimulates chicken
macrophages to produce NO and was used as a
positive control. For all samples, triplicate IFN-g
bioassays were performed. For HD11 cells
(Fig. 1(A)), both rTuIFN-g and rChIFN-g
induced similar levels of NO. Neither the super-
natants from mock-transfected COS-7 cells, nor
those from COS-7 cells transfected with pCIneo
alone, stimulated significant NO production. LPS
also induced HD11 cells to produce significant
levels of NO.
In case of LSTC-IAH30 cells (Fig. 1(B)), simi-
lar results were seen for rTuIFN-g and rChIFN-
g. The level of NO produced by LSTC-IAH30
cells was far less than that produced by HD11
cells. However, NO production from LSTC-
IAH30 cells, stimulated by rTuIFN-g and
rChIFN-g, was significantly greater than that
seen from the negative controls. One surprising
result was that LPS did not induce NO pro-
duction from LSTC-IAH30 cells (Figs. 1(B) and
3). However, this was later shown to be a sero-
type-specific result, as stimulation with LPS from
E. coli serotype 055:B26 caused NO production
by LSTC-IAH30 cells (results not shown).
A quantitative capture ELISA developed to
measure ChIFN-g [9] was also shown to measure
TuIFN-g. Supernatants from chicken (Fig. 2(A))
or turkey (Fig. 2(B)) splenocytes, cultured for 48
Table 1
Monoclonal antibodies used in FACS analysis
Monoclonal antibody Antigen specificity Reference/source
CC48 Undefined bovine antigen Howard, IAH
CC30 Bovine CD4 [10]
AV6 CD44 Davison, IAH
AV29 CD4 Davison, IAH
3-298 CD8a [11]
TCR2 TCRab1 Southern Biotechnology
AV7 CD28 [12]
M1 IgM [13]
K1 Thrombocyte/macrophage marker [14]
KULO1 Macrophage marker [15]
F21-21 b2M [16]
2G11 MHC class II [17]
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h in the presence of various mitogens, were tested
for IFN-g content using the ELISA. Super-
natants from LPS-treated splenocytes were added
as a positive control. Both chicken and turkey
splenocytes were stimulated to produce IFN-g, as
measured by the capture ELISA, following mito-
gen stimulation.
3.2. The biological activity of turkey IFN-g is
neutralised by mAb and pAb specific for chicken
IFN-g
To further illustrate the biological similarity
of TuIFN-g and ChIFN-g, an IFN-g neutralis-
ing assay was carried out. The anti-chicken
Fig. 1. IFN-g bioassay: NO production from HD11 (A) and LSTC-IAH30 (B) cells following 48 h stimulation with supernatants
from transfected COS-7 cells, or LPS (positive control — initial concentration 10 mg mlÿ1). Supernatants tested were harvested
from cells transfected with either no DNA (mock-transfected negative control), pCIneo alone (negative control), pCIneo expressing
ChIFNg or pCIneo expressing TuIFN-g. NO production was quantified using a modification of the Griess assay, measuring absor-
bance at 543 nm. Error bars represent standard error of the mean.
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IFN-g neutralising Abs used were 1E-12
(mAb) and 88 (pAb). A control mAb (CC30,
see Table 1), a control pAb (goat anti-mouse
IgG) or no Ab at all, were also included in
each assay. Test supernatants were diluted to
sub-optimal levels, based on the results seen in
the initial IFN-g assays (Fig. 1).
The anti-chicken IFN-g neutralising Abs 1E-12
and 88 both neutralised the NO-inducing activi-
ties of turkey and chicken IFN-g on both HD11
cells and LSTC-IAH30 cells (Fig. 3). Levels of
NO produced following pre-incubation with 1E-
12 and 88 were significantly lower P < 0:001
than those produced in all the controls,
approaching the background levels seen with the
pCIneo supernatants. As the rIFN-g induced
more NO production from HD11 cells than
LSTC-IAH30 cells (see earlier), the neutralising
eect was more obvious on HD11 cells. Neither
of the control Abs had any significant eects on
Fig. 1 (continued ).
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Fig. 2. IFN-g capture ELISA: IFN-g production from supernatants, from chicken (A) and turkey (B) splenocytes, following 48 h
stimulation with various mitogens, or LPS (E. coli serotype 0111:B4) (positive control).
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Fig. 3. IFN-g neutralising bioassay: NO production from HD11 and LSTC-IAH30 cells following 48 h co-incubation with either
IFN-g neutralising Abs (88 and 1E12), no Ab (negative control), CC30 (control mAb) or IgG polyclonal Ab (control pAb) and
either supernatants from transfected COS-7 cells (as described for Fig. 1) or LPS (E. coli serotype 055:B5) (positive control). Where
mean values for the groups dier significantly P < 0:01), the columns carry dierent letters. cmAb = control mAb; cpAb = con-
trol pAb.
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Fig. 4. FACS profiles of turkey (A) PBLs and (B) splenocytes showing the cross-reactivity with a variety of fluorescently tagged
anti-chicken mAb (see Table 1 for details). Negative controls were with no mAb present and an anti-bovine mAb, CC48. The y-
axis (events) measures the number of cells present in each sample and the x-axis (FL1-height) measures their fluorescent intensities.
The marker bar is set with reference to the control profiles and therefore indicates the cells stained positive for each test mAb.
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Fig. 5. FACS profiles of (A) HD11 and (B) LSTC-IAH30 cells showing the cross-reactivity with a variety of fluorescently tagged
anti-chicken mAb as described in Table 1. Negative controls were with no mAb present and an anti-bovine mAb, CC30.
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NO production, when compared to the no Ab
controls. The presence of Ab had no eect on
the levels of NO induced following incubation of
either HD11 cells or LSTC-IAH30 cells with
either LPS (NO assay positive control) or super-
natants from COS-7 cells transfected with pCI-
neo alone (NO assay negative control).
3.3. Characterisation of the expression of cell
surface markers on turkey PBLs and splenocytes,
and LSTC-IAH30 cells
LSTC-IAH30 cells are a previously unde-
scribed cell line. The method used to isolate
them, their morphology (data not shown) and
the bioassay results suggest that they are trans-
formed turkey macrophages. To characterise
them further, a comparison of cell surface mar-
ker expression on LSTC-IAH30 and HD11 cells
was carried out using flow cytometry. Initial
FACS analysis showed that a number of anti-
chicken mAbs (see Table 1) recognised molecules
on the surface of turkey PBLs (Fig. 4(A)) and
splenocytes (Fig. 4(B)). PBLs and splenocytes
stained positive for all antibodies used except
KULO1, which recognises a macrophage marker.
FACS analysis was carried out on HD11 and
LSTC-IAH30 cells with the same panel of anti-
chicken mAbs. The resulting FACS profiles are
shown in Fig. 5(A) (HD11 cells) and Fig. 5(B)
(LSTC-IAH30 cells). The mAbs K1 (thrombo-
cyte/macrophage marker) and F21-21 (b2M)
stained both HD11 and LSTC-IAH30 cells,
although staining was stronger with both mAbs
on HD11 cells. LSTC-IAH30 cells were essen-
tially negative for all other markers. HD11 cells
were also positive for the macrophage cell surface
antigen recognised by KULO1, CD44 (AV6),
and MHC Class II (2G11).
4. Discussion
We had previously shown that IFN-g shares
high aa identity among the galliforms [2], which
led us to predict cross-species reactivity. The data
presented here conclusively show that rTuIFN-g
and rChIFN-g are indeed cross-reactive and both
can function equally well in either system.
Further, mAb (1E-12) and pAb (88) raised to
ChIFN-g, which neutralise the biological activi-
ties of ChIFN-g, also neutralise the NO-inducing
activity of TuIFN-g.
Two dierent cell lines were used to investigate
the biological properties of rTuIFN-g and
rChIFN-g, HD11 cells (a well-characterised
chicken macrophage cell line [7,18]) and LSTC-
IAH30 cells (a turkey cell line). The relative
amount of NO produced by the two cell lines dif-
fered, with HD11 cells producing approximately
five-fold higher maximal levels of NO than
LSTC-IAH30 cells. However, the levels of NO
production stimulated by either rTuIFN-g or
rChIFN-g on either cell line were similar. Light
microscopy showed that both HD11 and LSTC-
IAH30 cell cultures were confluent after 48 h in-
cubation in the presence of the rIFN-g, arguing
against LSTC-IAH30 cells having a slower
growth rate than HD11 cells. The most likely ex-
planation for the dierence in induced NO levels
is that the transformed turkey macrophages react
less well to IFN-g stimulation than the trans-
formed chicken macrophages.
To further characterise the LSTC-IAH30 cell
line, FACS analysis was used to compare the ex-
pression of cell surface molecules on HD11 and
LSTC-IAH30 cells. Initially, turkey PBLs and
splenocytes were used to determine which anti-
chicken mAbs recognised epitopes on molecules
on the surface of turkey cells. It should be
stressed that these mAbs may not be recognising
the same molecule on turkey cells as on chicken
cells. There is, however, high identity between the
turkey and chicken homologues of Bu-1, CD4,
CD8, CD28, and CD44 (84–95% aa identity,
data not shown). Further, other anti-chicken
CD4 and CD8 mAbs have been shown to cross-
react with turkey PBLs [19], including one of the
anti-chicken CD8 mAbs used in this study, 3-
298. This mAb was shown to distinguish two
dierent populations in single-colour FACS
staining, suggesting, as is the case with the
chicken [20], polymorphism of the turkey mol-
ecule. Immunoprecipitation and Western blotting
showed that 3-298 precipitated a 33–35 kDa
polypeptide similar to the relative molecular
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mass of the chicken CD8 molecule [21,22]. For
the purposes of this study, we have therefore
assumed that the anti-chicken mAbs recognise
the same molecules on turkey cells.
HD11 cells stained positive for AV6, K1,
KULO1, F21-21 and 2G11 (albeit weakly). K1
and KULO1 recognise macrophage markers,
CD44 (AV6) is a widely expressed marker on
both haematopoietic and non-haematopoietic
cells, whilst F21-21 and 2G11 recognise class I
and class II major histocompatability complex
antigens respectively. LSTC-IAH30 cells were
only positive for some of these markers, specifi-
cally those recognised by the mAbs K1 and F21-
21, and also possibly M1 (which recognises IgM),
but not KULO1. However, turkey PBLs and
splenocytes were also negative for KULO1. To
confirm the specificity of the mAbs used in this
study, we are cloning the turkey orthologues of
the respective chicken genes.
The finding that turkey and chicken IFN-g
cross-react was predicted from the high level of
sequence identity. This cross-reactivity was some-
what dierent to the species-specificity originally
observed with human IFNg (huIFN-g) and
mouse IFN-g [23], which share only 40% identity
at the aa level [24]. More closely related mamma-
lian species do share high identity at the pre-
dicted protein level and are cross-reactive. For
example, huIFN-g and rhesus monkey IFN-g are
93.9% aa identical and cross-react [25]; caprine
and bovine IFN-g are 95.2% aa identical and
also cross-react [26,27].
This work suggests that it may be more plaus-
ible to use rChIFN-g, instead of TuIFN-g, as a
vaccine adjuvant against turkey diseases, because
the pure recombinant chicken protein is already
available and fully characterised [28–30]. Evi-
dence for recombinant ChIFN-g having ecacy
as a vaccine adjuvant and also as an immunomo-
dulator has recently been demonstrated [31,32].
Here we have shown cross-species reactivity
between the chicken and the turkey for IFN-g.
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